A new BASF production plant for the intermediate 2-mercaptoethanol (2-ME) at the Ludwigshafen Verbund site started regular operations in the fourth quarter of 2021. After a trial run of several months, it replaces the previous plant at the Ludwigshafen site, which is being closed after more than 40 years of operation. The new plant is fully integrated into BASF's production Verbund and, with more than 10,000 metric tons of 2-ME per year, has the same production capacity as the previous plant. 2-ME has proven its value in the production of plastics, crop protection products, oilfield chemicals (Basocorr® ME) and coatings.
"The new plant will enable us to supply our customers all over the world with 2-mercaptoethanol even more reliably. Our global logistics network, which our customers can further rely on, also contributes to this," says Frank Stein, head of the Regional Business Unit Europe in BASF's Intermediates division.
Air Products to Start Construction of Second Liquid Hydrogen Plant in Rotterdam, The Netherlands
New plant brings additional liquid hydrogen capacity to Europe. Once operational in 2025, the plant will double Europe’s total current liquid hydrogen capacity.
ADM Opens New Extrusion Facility in Serbia, Meeting Accelerated Demand for Textured Soy Proteins
The new facility increases ADM’s extrusion capacity in the European region. As an extension of its non-GMO solutions, ADM will now offer both origination and extrusion capabilities of non-GMO soy p...
Mura Technology and Dow plan to locate Europe’s largest advanced recycling facility at Dow’s site in Böhlen, Germany
Mura plans to construct a new facility at Dow’s Böhlen site in Germany – the latest in a series of planned facilities across the U.S. and Europe to rapidly scale advanced recycling of plastics – a...
Merck Invests More Than € 130 Million to Strengthen Manufacturing Capabilities in Molsheim, France
Increases manufacturing capacity for the Mobius® single-use portfolio. Creates more than 800 jobs by the end of 2028. Investment further strengthens Merck's "Big 3," the key drivers for increasing ...